Abstract
Abstract
Background
Endocrine disorders are heterogeneous and include a significant number of rare monogenic diseases.
Methods
We performed exome sequencing (ES) in 106 children recruited from a single center within the TRANSLATE‑NAMSE project. They were categorized into subgroups: proportionate short stature (PSS), disproportionate short stature (DSS), hypopituitarism (H), differences in sexual development (DSD), syndromic diseases (SD) and others.
Results
The overall diagnostic yield was 34.9% (n = 37/106), including 5 patients with variants in candidate genes, which have contributed to collaborations to identify gene-disease associations. The diagnostic yield varied significantly between subgroups: PSS: 16.6% (1/6); DSS: 18.8% (3/16); H: 17.1% (6/35); DSD: 37.5% (3/8); SD: 66.6% (22/33); others: 25% (2/8). Confirmed diagnoses included 75% ultrarare diseases. Three patients harbored more than one disease-causing variant, resulting in dual diagnoses.
Conclusions
ES is an effective tool for genetic diagnosis in pediatric patients with complex endocrine diseases. An accurate phenotypic description, including comprehensive endocrine diagnostics, as well as the evaluation of variants in multidisciplinary case conferences involving geneticists, are necessary for personalized diagnostic care. Here, we illustrate the broad spectrum of genetic endocrinopathies that have led to the initiation of specific treatment, surveillance, and family counseling.
Graphical Abstract
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference29 articles.
1. Shlomo M., Auchus R.J., Goldfine A.B., Koenig R.J., Rosen C.J. Williams textbook of endocrinology. Philadelphia: Elsevier; 2020.
2. Bundesausschuss IbG: TRANSLATE-NAMSE – Verbesserung der Versorgung von Menschen mit seltenen Erkrankungen durch Umsetzung von im nationalen Aktionsplan (NAMSE) konsentierten Maßnahmen. https://innovationsfonds.g-ba.de/projekte/neue-versorgungsformen/translate-namse-verbesserung-der-versorgung-von-menschen-mit-seltenen-erkrankungen-durch-umsetzung-von-im-nationalen-aktionsplan-namse-konsentierten-massnahmen.78 (2017). Accessed 20.01.2023.
3. S. Kohler, M. Gargano, N. Matentzoglu, L.C. Carmody, D. Lewis-Smith, N.A. Vasilevsky et al. The human phenotype ontology in 2021. Nucleic Acids Res 49(D1), D1207–D1217 (2021). https://doi.org/10.1093/nar/gkaa1043
4. E.R. Riggs, E.F. Andersen, A.M. Cherry, S. Kantarci, H. Kearney, A. Patel et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med 22(2), 245–257 (2020). https://doi.org/10.1038/s41436-019-0686-8
5. S. Richards, N. Aziz, S. Bale, D. Bick, S. Das, J. Gastier-Foster et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5), 405–424 (2015). https://doi.org/10.1038/gim.2015.30